| Q39393721 | A case of anorexia nervosa with comorbid Crohn's disease: beneficial effects of anti-TNF-α therapy? |
| Q30357655 | Adipocytokines in obesity and metabolic disease. |
| Q38784887 | Adipokines in Healthy Skeletal Muscle and Metabolic Disease |
| Q36560588 | Altered response of skeletal muscle to IL-6 in type 2 diabetic patients |
| Q52669792 | Association between high serum carcinoembryonic antigen and clinical state of male anorexia nervosa: A case report. |
| Q92343438 | Beige Fat, Adaptive Thermogenesis, and Its Regulation by Exercise and Thyroid Hormone |
| Q34316238 | Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. |
| Q38025974 | Continuous glucose monitoring in children and adolescents |
| Q35195052 | Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse |
| Q33968320 | Disassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance |
| Q29619888 | Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis |
| Q58107270 | Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism |
| Q30361595 | From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. |
| Q48200213 | Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle. |
| Q39015204 | Gastrointestinal comorbidities which complicate the treatment of anorexia nervosa |
| Q36410031 | Growth hormone modulates hypothalamic inflammation in long-lived pituitary dwarf mice |
| Q34086574 | HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance |
| Q33600513 | Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons |
| Q27323584 | IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition |
| Q56240296 | IL-6 regulates exercise and training-induced adaptations in subcutaneous adipose tissue in mice |
| Q37968599 | IL-6/IL-6R as a potential key signaling pathway in prostate cancer development |
| Q58725702 | IL-6: A Potential Role in Cardiac Metabolic Homeostasis |
| Q64387657 | IL1R1 is required for celastrol’s leptin-sensitization and antiobesity effects |
| Q82249175 | IL6 as a mediator of insulin resistance: fat or fiction? |
| Q35993401 | IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action |
| Q41665611 | In vitro anti-inflammatory effects of citrulline on peritoneal macrophages in Zucker diabetic fatty rats |
| Q38732966 | Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction |
| Q33865096 | Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms |
| Q45288120 | Inter-relation between interleukin (IL)-1, IL-6 and body fat regulating circuits of the hypothalamic arcuate nucleus. |
| Q34857481 | Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. |
| Q91592796 | Interleukin-6 in the central amygdala is bioactive and co-localised with glucagon-like peptide-1 receptor |
| Q26866208 | Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? |
| Q47376918 | Interleukin-6 regulates the expression of hypothalamic neuropeptides involved in body weight in a gender-dependent way. |
| Q84707922 | Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance |
| Q37594442 | Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis |
| Q59326168 | Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases? |
| Q38319544 | Leptin and leucine synergistically regulate protein metabolism in C2C12 myotubes and mouse skeletal muscles |
| Q57462637 | Leptin and the intervertebral disc: a biochemical link exists between obesity, intervertebral disc degeneration and low back pain-an in vitro study in a bovine model |
| Q53508307 | Leukemia inhibitory factor increases glucose uptake in mouse skeletal muscle. |
| Q33701511 | Long-lived crowded-litter mice exhibit lasting effects on insulin sensitivity and energy homeostasis |
| Q35273848 | Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice |
| Q35123484 | Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance. |
| Q34031701 | Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training |
| Q51541906 | Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models. |
| Q34132288 | Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. |
| Q36906688 | Modeling and experiments of magneto-nanosensors for diagnostics of radiation exposure and cancer |
| Q34265667 | Muscles, exercise and obesity: skeletal muscle as a secretory organ |
| Q38199992 | Myokines in insulin resistance and type 2 diabetes. |
| Q83965043 | Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis |
| Q38141219 | Physical inactivity, insulin resistance, and the oxidative-inflammatory loop |
| Q35905154 | Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies. |
| Q42011586 | Preproglucagon neurons in the hindbrain have IL-6 receptor-α and show Ca2+ influx in response to IL-6. |
| Q91736923 | Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer |
| Q34893465 | Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk |
| Q47650330 | Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production |
| Q34166632 | Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin |
| Q38134113 | Targeting gp130 to prevent inflammation and promote insulin action. |
| Q37715588 | The Baf60c/Deptor pathway links skeletal muscle inflammation to glucose homeostasis in obesity |
| Q38992755 | The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism |
| Q26770548 | The role of gp130 receptor cytokines in the regulation of metabolic homeostasis |
| Q35588690 | Transient early food restriction leads to hypothalamic changes in the long-lived crowded litter female mice |
| Q37950733 | Why do anti-inflammatory therapies fail to improve insulin sensitivity? |